Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKY0402 Phase 2 Dose-Ranging Study in TKA
NCT00485693Phase 2Completed
- Sponsor
- Pacira BioSciences
- Start
- Jun 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of bupivacaine liposome in postoperative pain, sponsored by Pacira BioSciences. Started Jun 2007; status: completed.
02
Drugs
bupivacaine liposome
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00485693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00485693.